Elevated liver enzymes after olanzapine use: a case report

Authors

  • Samreen Ahmed Department of Psychiatry, Brookdale University Hospital and Medical Center, Brooklyn, New York, USA
  • Saima Warraich Department of Psychiatry, Brookdale University Hospital and Medical Center, Brooklyn, New York, USA

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20160130

Keywords:

Olanzapine, Liver enzymes, Bipolar mania

Abstract

Olanzapine is a second-generation antipsychotic used in bipolar mania and schizophrenia. We are reporting the case of a young female patient who developed elevated liver enzymes after olanzapine use. Patient's liver enzymes improved after the discontinuation of olanzapine making it a possible cause for reversible hepatotoxicity. We recommend physicians to check liver enzymes regularly if patient is on olanzapine.

Metrics

Metrics Loading ...

References

Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry. 2005;10(1):79-104.

Manceaux P, Constant E, Zdanowicz N, Jacques D, Reynaert C. Management of marked liver enzyme increase during olanzapine treatment: a case report and review of the literature. Psychiatr Danub. 2011;23(1):S15-17.

Divac N, Prostran M, Jakovcevski I, Cerovac N. Second generation antipsychotics and extrapyramidal adverse effects. BioMed Res Intl. 2014;2014. http://dx.doi.org/10.1155/2014/656370.

Tikka SK, Pratap A, Sinha VK. Dose-dependent Olanzapine-induced myolonus. Toxicol Int. 2014;21(3):335-6.

Sun Z, Wang X. Case report of refractory tardive dystonia induced by olanzapine. B Shanghai Arch Psychiatry. 2014;26(1):51-3.

Basu A, Kundu S, Khurana H. Olanzapine-induced restless leg syndrome: A case report and review of literature. Indian J Pharmacol. 2014;46:450-2.

Kerr TA, Jonnalagadda S, Prakash C, Azar R. Pancreatitis following olanzapine Therapy: A report of three cases. Case Rep Gastroenterol. 2007;1(1):15-20.

Tuglu C, Erdogan E, Abay E. Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: A case report. J Korean Med Sci. 2005;20(4):691-4.

Olsson R, Zettergren L. Anticonvulsant-induced liver damage. Am J Gastroenterol. 1988;83(5):576-7.

Atasoy N, Erdogan A, Yalug I, Ozturk U, Konuk N, Atik L et al. A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(6):1255-60.

Downloads

Published

2016-12-24

How to Cite

Ahmed, S., & Warraich, S. (2016). Elevated liver enzymes after olanzapine use: a case report. International Journal of Basic & Clinical Pharmacology, 5(1), 213–214. https://doi.org/10.18203/2319-2003.ijbcp20160130